Impact of Patient and Physician Disconnect on Satisfaction with Treatment for Atopic Dermatitis in Japan

Wang, Chaochen; Aranishi, Toshihiko; Reed, Catherine; Anderson, Peter; Austin, Jennifer; Davis, Victoria A.; Quinones, Emily; Piercy, James

doi:10.1007/s13555-022-00866-z

Cited by 3 publications

(3 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The trend is also similar to reports in Japan for other chronic skin conditions such as atopic dermatitis 39,41–43 and psoriasis 44,45 . For example, Wang et al reported that mean absenteeism, presenteeism, overall work impairment, and activity impairment in Japanese patients with atopic dermatitis were 2.8 ± 9.5%, 31.0 ± 23.4%, 31.6 ± 24.9%, and 34.8 ± 24.5%, respectively 43 . In our study, the respective values were 0.9 ± 2.8%, 23.9 ± 25.7%, 24.3 ± 25.8%, and 35.0 ± 29.5%.…”

Section: Discussionsupporting

confidence: 84%

“…This was comparable with results found in the US. 27,28 The trend is also similar to reports in Japan for other chronic skin conditions such as atopic dermatitis 39,[41][42][43] and psoriasis. 44,45 43 In our study, the respective values were 0.9 ± 2.8%, 23.9 ± 25.7%, 24.3 ± 25.8%, and 35.0 ± 29.5%.…”

Section: Discussionsupporting

confidence: 83%

“…27,28 The trend is also similar to reports in Japan for other chronic skin conditions such as atopic dermatitis 39,[41][42][43] and psoriasis. 44,45 43 In our study, the respective values were 0.9 ± 2.8%, 23.9 ± 25.7%, 24.3 ± 25.8%, and 35.0 ± 29.5%. Since AA is not a disease which interferes with physical activity, it does not have a major impact on absenteeism.…”

Section: Discussionsupporting

confidence: 83%

See 2 more Smart Citations

Economic burden of alopecia areata: A study of direct and indirect cost in Japan using real‐world data

Ohyama

Kamei

Yuasa

et al. 2023

The Journal of Dermatology

Self Cite

View full text Add to dashboard Cite

Alopecia area (AA) is a common autoimmune disorder, characterized by hair loss. Although its impact on quality of life is fairly well understood, studies on the economic impact of AA are limited. The aim of this study was to quantify the personal and nationwide economic burden of AA in Japan. Data were drawn from the Adelphi AA Disease Specific Programme (DSP)™, a real‐world, cross‐sectional survey with retrospective data collection, of Japanese physicians and patients with AA. The study was conducted in 2021, before the approval of Janus kinase inhibitors for AA. Physicians and their consulting AA patients completed questionnaires regarding disease severity, treatment, and AA‐related costs. The Work Productivity and Activity Impairment questionnaire was used to evaluate the impact of AA on patients' work and activity. Nationwide estimates of cost and productivity loss were extrapolated from collected patient data. A total of 50 physicians provided data on 235 patients; 58.7% were female, mean ± SD age was 41.1 ± 11.8 years, and mean physician‐estimated scalp hair loss was 40.4% ± 30.2%. Prescription medication use was high (92.3% of patients), but the use of over‐the‐counter medication was low, at 8.7%. Mean cost to patients for medication was ¥ 4263 (US$ 32.42) per month. Productivity while at work (presenteeism) was significantly impaired (23.9% ± 25.7%), but absenteeism was low (0.9% ± 2.8%). The total nationwide cost of AA was estimated at 112.7 billion yen (US$ 857 million), of which 88.1 billion yen (78.2%) was due to productivity loss. Over 2 million days per year of activity time were estimated to be lost due to AA. Thus, despite not being a physically limiting disease, AA has a significant impact in terms of cost and time, both on a personal and national level. These data highlight the need for more targeted interventions to reduce the effects of AA on the Japanese economy.

show abstract

Section: Discussionsupporting

confidence: 84%

Section: Discussionsupporting

confidence: 83%

Section: Discussionsupporting

confidence: 83%

See 1 more Smart Citation

Economic burden of alopecia areata: A study of direct and indirect cost in Japan using real‐world data

Ohyama

Kamei

Yuasa

et al. 2023

The Journal of Dermatology

Self Cite

View full text Add to dashboard Cite

show abstract

Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes

Anderson,

Higgins,

Courcy

et al. 2023

Current Medical Research and Opinion

View full text Add to dashboard Cite

The atopic dermatitis patient journey: insights from a qualitative study

Kpenou,

Paul,

Seneschal

et al. 2024

British Journal of Dermatology

View full text Add to dashboard Cite

This qualitative study aimed to explore adults’ experiences with AD and gain insight into their expectations regarding its healthcare in order to improve AD patients’ well-being. Data from 21 interviews were analyzed. Volunteers reported a significant burden due to AD psychosocial impact, encompassing both emotional distress and daily life impediments. Factors influencing treatment satisfaction among AD patients extend beyond clinical efficacy. Dermatological care should consider patients’ preferences within treatment plans through a holistic approach to ensure satisfaction with their therapeutic regimen. We therefore encourage efforts to promote collaborative discussions between patients and physicians to improve treatment satisfaction.

show abstract

Impact of Patient and Physician Disconnect on Satisfaction with Treatment for Atopic Dermatitis in Japan

Cited by 3 publications

References 31 publications

Economic burden of alopecia areata: A study of direct and indirect cost in Japan using real‐world data

Economic burden of alopecia areata: A study of direct and indirect cost in Japan using real‐world data

Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes

The atopic dermatitis patient journey: insights from a qualitative study

Contact Info

Product

Resources

About